TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.

Jonathan M Loree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.